Skip to content

Efficacy of combining CO2 laser with amorolfine 5 percent nail lacquer in treatment of onychomycosis An open label randomised controlled trial

Efficacy of combining CO2 laser with Amrolofine 5% nail laqure in treatment of Onychomycosis- An open label randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089309
Enrollment
60
Registered
2025-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B351- Tinea unguium

Interventions

Intervention1: CO2 laser followed by application of Amorolfine nail laquer: Total of 6 sittings C02 laser of the affected nail every 3 weekly followed by application of amorolfine nail laquer Control

Sponsors

AIIMS GORAKHPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All diagnosed patients of onychomycosis (clinically and mycologically) with age more than 12 years 2. Patients with distal subungual onychomycosis, white superficial onychomycosis, max. 40 percent of the nail surface affected. 3. Patients with mild to moderate onychomycosis (with OSI less than equal to 15) 4. Patients who are willing for CO2 lser.

Exclusion criteria

Exclusion criteria: 1. Patients having localized bacterial infection around the affected nail or concomitant nail disease that causes nail dystrophy or discoloration such as psoriasis, lichen planus and atopic dermatitis that may interfere with diagnosis and treatment. 2. Patients with history of intake of oral antifungal medication within the last 3 months or the use of topical antifungal medication within the last 2 weeks prior to the laser treatment. 3. Pregnant patient

Design outcomes

Primary

MeasureTime frame
1. Percentage of nail achieving of CER and MCR at the end of 24 week and its comparision between the 2 group. 2. Change in OSI from baseline to 24 weeks within both the groups.Timepoint: Baseline, 18 weeks, 24 weeks

Secondary

MeasureTime frame
1. Comparision of recurrence rate in both the group during 3 month follow up after completion of CO2 laser treatment. 2. Correlation of improvement in CER & MCR with the fungal species.Timepoint: Baseline,24 weeks, 36 weeks

Countries

India

Contacts

Public ContactSHIWANGI RANA

Department of Dermatology,AIIMS

shivangi.rana356@gmail.com8860565443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026